BridgeBio Pharma Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $14.9M | — |
| FY2017 | — | $85.9M | $92.0M |
| FY2018 | $54.5M | $314.9M | $436.1M |
| FY2019 | $91.8M | $408.5M | $363.8M |
| FY2020 | $92.4M | $57.9M | $356.1M |
| FY2021 | $430.8M | $-870.4M | $393.8M |
| FY2022 | $431.0M | $-1.25B | $376.7M |
| FY2023 | $446.4M | $-1.35B | $375.9M |
| FY2024 | $437.3M | $-1.47B | $681.1M |
| FY2025 | $2.01B | $-2.09B | $570.1M |